Difference between revisions of "Case 112"

Jump to navigation Jump to search
51 bytes added ,  05:07, 29 September 2015
no edit summary
 
(8 intermediate revisions by 3 users not shown)
Line 3: Line 3:


===Site===
===Site===
ZZZ
Left ovary


===Primary image===
===Primary image===
[[Image: Gross of borderline serous tumor of the ovary 01.jpg|500px|link=|center|]]
[[Image: Gross of borderline serous tumor of the ovary 01.jpg|500px|link=|center|]]
<center>Gross image.</center>
<br>
[[Image:  Low maginification of borderline serous tumor of the ovary.jpg|500px|link=|center|]]
<center>Low magnification. [[H&E stain]].</center>
<center>Low magnification. [[H&E stain]].</center>
{{hidden|Intermediate magnification|[[Image: Low maginification of borderline serous tumor of the ovary.jpg |500px|link=|center|]]
<center>Intermediate magnification. [[H&E stain]].</center>}}


{{hidden|High magnification|[[Image: Intermediate magnification of a borderline serous tumor showing eosiniophilic cells.jpg |500px|link=|center|]]
{{hidden|High magnification|[[Image: Intermediate magnification of a borderline serous tumor showing eosiniophilic cells.jpg |500px|link=|center|]]
<center>High magnification. [[H&E stain]].</center>}}
<center>High magnification. [[H&E stain]].</center>}}


{{hidden|High magnification|[[Image: Microinvasion in a borderline serous tumor of the ovary.jpg |500px|link=|center|]]
{{hidden|High magnification|[[Image: Microinvasion in a borderline serous tumor of the ovary.jpg |500px|link=|center|]]
<center>High magnification. [[H&E stain]].</center>}}
<center>High magnification. [[H&E stain]].</center>}}


===Differential diagnosis===
===Differential diagnosis===
Line 274: Line 272:


===Diagnosis===
===Diagnosis===
{{hidden|Diagnosis|<center>BORDERLINE SEROUS TUMOR OF THE OVARY WITH MICROINVASION.</center>   
{{hidden|Diagnosis|<center>[[serous borderline tumour of the ovary|BORDERLINE SEROUS TUMOR OF THE OVARY]] WITH MICROINVASION.</center>   
<br>The characteristic feature of borderline serous tumor is the hierarchical branching of the papillae, where the papillae progressively branch from larger ones to smaller one and finally into tufts of epithelial cells.  The cells show only mild to moderate atypia.  A cytadenofibroma may have similar proliferation, but by convention should be less than 5% of the tumor.  Focal mucinous change may also occur. Papillary clear cell carcinoma simulating borderline tumor will show a WT1-ve, ER-ve, PR-ve immunoprofile in contrast to the positive profile of the serous tumor.  Often clusters of cells with abundant eosinophilic cytoplasm are seen at the surface of papillae (star, image 2; oval image 3) or in lymphatic like spaces either as single cells or small papillary clusters. This theoretically represents microinvasion which is variably defined by different authors (<3 or 5 mm or 10mm2).  However, recent evidence suggests that the two patterns of invasion have vastly different prognosis.  The AEC (abundant eosinophilic cells) are p16 positive and reflect a terminally differentiated senescent phenotype.  If invasion is exclusively composed of this cell type, then these do not portend a poor prognosis.<ref name=pmid24441661>{{Cite journal  | last1 = Maniar | first1 = KP. | last2 = Wang | first2 = Y. | last3 = Visvanathan | first3 = K. | last4 = Shih | first4 = IeM. | last5 = Kurman | first5 = RJ. | title = Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases. | journal = Am J Surg Pathol | volume = 38 | issue = 6 | pages = 743-55 | month = Jun | year = 2014 | doi = 10.1097/PAS.0000000000000155 | PMID = 24441661 }}</ref>  These cells are significantly more often seen in BRAF mutated tumors, and are perhaps associated with a better prognosis. {{Cite journal  | last1 = Zeppernick | first1 = F. | last2 = Ardighieri | first2 = L. | last3 = Hannibal | first3 = CG. | last4 = Vang | first4 = R. | last5 = Junge | first5 = J. | last6 = Kjaer | first6 = SK. | last7 = Zhang | first7 = R. | last8 = Kurman | first8 = RJ. | last9 = Shih | first9 = IeM. | title = BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors. | journal = Am J Surg Pathol | volume = 38 | issue = 12 | pages = 1603-11 | month = Dec | year = 2014 | doi = 10.1097/PAS.0000000000000313 | PMID = 25188864 }}
<br>The characteristic feature of borderline serous tumor is the hierarchical branching of the papillae, where the papillae progressively branch from larger ones to smaller one and finally into tufts of epithelial cells.  The cells show only mild to moderate atypia.  A cytadenofibroma may have similar proliferation, but by convention should be less than 5% of the tumor.  Focal mucinous change may also occur. Papillary clear cell carcinoma simulating borderline tumor will show a WT1-ve, ER-ve, PR-ve immunoprofile in contrast to the positive profile of the serous tumor.  Often clusters of cells with abundant eosinophilic cytoplasm are seen at the surface of papillae (star, image 2; oval image 3) or in lymphatic like spaces either as single cells or small papillary clusters. This theoretically represents microinvasion which is variably defined by different authors (<3 or 5 mm or 10mm<sup>2</sup>).  However, recent evidence suggests that the two patterns of invasion have vastly different prognosis.  The AEC (abundant eosinophilic cells) are [[p16]] positive and reflect a terminally differentiated senescent phenotype.  If invasion is exclusively composed of this cell type, then these do not portend a poor prognosis.<ref name=pmid24441661>{{Cite journal  | last1 = Maniar | first1 = KP. | last2 = Wang | first2 = Y. | last3 = Visvanathan | first3 = K. | last4 = Shih | first4 = IeM. | last5 = Kurman | first5 = RJ. | title = Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases. | journal = Am J Surg Pathol | volume = 38 | issue = 6 | pages = 743-55 | month = Jun | year = 2014 | doi = 10.1097/PAS.0000000000000155 | PMID = 24441661 }}</ref>  These cells are significantly more often seen in BRAF mutated tumors, and are perhaps associated with a better prognosis.<ref name=pmid25188864>{{Cite journal  | last1 = Zeppernick | first1 = F. | last2 = Ardighieri | first2 = L. | last3 = Hannibal | first3 = CG. | last4 = Vang | first4 = R. | last5 = Junge | first5 = J. | last6 = Kjaer | first6 = SK. | last7 = Zhang | first7 = R. | last8 = Kurman | first8 = RJ. | last9 = Shih | first9 = IeM. | title = BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors. | journal = Am J Surg Pathol | volume = 38 | issue = 12 | pages = 1603-11 | month = Dec | year = 2014 | doi = 10.1097/PAS.0000000000000313 | PMID = 25188864 }}</ref>


====References====
====References====
Line 290: Line 288:
[[Category:Cases]]
[[Category:Cases]]


<!-- SELECT A CATEGORY
 
[[Category:Cases in gynecological pathology]]
[[Category:Cases in gynecologic pathology]]
-->
[[Category:Cases in gynecologic pathology - junior]]


[[Category:Cases difficulty 2]] <!-- difficulty 1-7 -- should roughly correspond to the PGY level -->
[[Category:Cases difficulty 2]] <!-- difficulty 1-7 -- should roughly correspond to the PGY level -->
48,466

edits

Navigation menu